I’m honored to serve as chairman and CEO for Merck, known as MSD outside the United States and Canada. Under my leadership, the company remains fully committed to leading-edge science and saving and improving lives around the world. I’m fortunate to have been a part of the Merck family since 2014. I’ve seen firsthand our long-standing commitment to science, innovation and improving global health, and believe that we’re unsurpassed among pharmaceutical companies – especially when it comes to our people. As the world faces no shortage of challenges, I’m confident that together we’ll continue to do what we do best: discover and deliver new medicines and vaccines that address important unmet human and animal health needs.